Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
St. Maria is a Japanese biotechnology company specializing in regenerative medicine and advanced cell therapy services. The company operates high-standard Cell Processing Centers (CPC) that focus on the cultivation and administration of adipose-derived stem cells (ADSCs) for various medical and aesthetic applications. Their primary business model involves providing personalized stem cell treatments for indications such as osteoarthritis, diabetes, and chronic pain, while also offering cell processing services to medical institutions. St. Maria is dedicated to advancing the clinical application of regenerative medicine through rigorous safety standards and innovative cell culture technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on StMaria.